Dr. Michelson Advocates for Establishing a “National Institute for Cures” to Fast-Track Drug and Vaccine Development
The COVID-19 pandemic has created the need for an accelerated drug development paradigm to bring vaccines to the masses. Several public-private partnerships, including Operation Warp Speed, helped fund an accelerated research & development framework in which low-risk vaccines, likely to be successful, were supported via federal spending. Michelson Philanthropies founder Dr. Gary Michelson makes the case for why increased fast tracking of funding and development for innovative scientific developments is key for our future in the latest COVID-19 edition of National Academy of Inventors’ Technology & Innovation Journal.